Home/Filings/4/0001562180-21-006188
4//SEC Filing

Spellman David A 4

Accession 0001562180-21-006188

CIK 0001517022other

Filed

Sep 30, 8:00 PM ET

Accepted

Oct 1, 4:06 PM ET

Size

5.6 KB

Accession

0001562180-21-006188

Insider Transaction Report

Form 4
Period: 2021-09-30
Spellman David A
SVP, CFO and Treasurer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2021-09-30+200,000200,000 total
    Exercise: $2.88Exp: 2031-09-30Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Issuer

Akebia Therapeutics, Inc.

CIK 0001517022

Entity typeother

Related Parties

1
  • filerCIK 0001733204

Filing Metadata

Form type
4
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 4:06 PM ET
Size
5.6 KB